Bluebird Bio Inc (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -211,913 | -131,091 | -43,859 | 18,930 | -230,342 |
| Depreciation Amortization | 28,525 | 19,660 | 12,250 | 6,172 | 8,344 |
| Accounts receivable | N/A | -14,600 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,841 | 1,712 | -5,623 | 1,260 | -7,709 |
| Other Working Capital | -49,721 | -46,990 | -39,205 | -20,497 | -75,044 |
| Other Operating Activity | -4,778 | -9,601 | -54,422 | -77,223 | -11,468 |
| Operating Cash Flow | $-235,046 | $-180,910 | $-130,859 | $-71,358 | $-316,219 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 71,077 | 62,077 | -2,044 | -9,736 | 161,661 |
| PPE Investments | -4,189 | -2,975 | -937 | -232 | -8,208 |
| Purchase Sale Intangibles | -4,868 | -868 | -868 | -868 | -5,000 |
| Other Investing Activity | 88,062 | 92,062 | 92,062 | 92,104 | 97,000 |
| Investing Cash Flow | $154,950 | $151,164 | $89,081 | $82,136 | $250,453 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -54,367 | -40,299 | -28,504 | -15,280 | -36,734 |
| Common Stock Issued | 248,198 | 130,165 | 130,207 | 130,652 | 54,237 |
| Common Stock Repurchased | N/A | -196 | -196 | -196 | N/A |
| Other Financing Activity | 2,417 | 0 | 0 | 0 | 16 |
| Financing Cash Flow | $196,248 | $89,670 | $101,507 | $115,176 | $17,519 |
| Beginning Cash Position | 158,445 | 158,445 | 158,445 | 158,445 | 206,692 |
| End Cash Position | 274,597 | 218,369 | 218,174 | 284,399 | 158,445 |
| Net Cash Flow | $116,152 | $59,924 | $59,729 | $125,954 | $-48,247 |
| Free Cash Flow | |||||
| Operating Cash Flow | -235,046 | -180,910 | -130,859 | -71,358 | -316,219 |
| Capital Expenditure | -4,189 | -2,975 | -937 | -232 | -8,208 |
| Free Cash Flow | -239,235 | -183,885 | -131,796 | -71,590 | -324,427 |